Transcription factor LbUBC positively regulates salt gland development and salt tolerance by directly binding to the LbTTG1 promoter and repressing its transcription
Plant Cell Reports · 2026
DOI: 10.1007/s00299-026-03950-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Cell Reports, 2026. Verfasst von Shuyue Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Plant Stress Biology and Genetic Improvement, College of Life Sciences, Shandong Normal University, Ji'nan, 250…. Hauptthemen laut MEDLINE: Salt Tolerance, Transcription Factors, Plant Proteins, Promoter Regions, Genetic. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Shandong Province Excellent Youth Science Fund, National Natural Science Research Foundation of China.
Abstract (Originalsprache)
KEY MESSAGE:: LbUBC enhances salt tolerance by promoting salt gland development via repressing LbTTG1, revealing a synergisticregulatory mechanism in Limonium bicolor. In the context of increasingly severe soil salinization, salt-tolerant genetic resources from halophytes show great application potential. In particular, the recretohalophyte Limonium bicolor, which possesses specialized salt gland structures, has become a key model for deciphering the molecular mechanisms underlying salt tolerance and salt gland development. In this study, using LbTTG1-overexpressing and -silenced lines, we demonstrate that LbTTG1 negatively regulates salt-gland development and salt tolerance. Through yeast one-hybrid, EMSA, and dual-luciferase assays, Lb7G33228 (LbUBC) was screened and verified as an upstream transcriptional regulator of LbTTG1. LbUBC enhances salt tolerance in L. bicolor by positively regulating salt-gland development, verified using LbUBC silence and overexpression strains. Interestingly, LbUBC represses the expression of its downstream target LbTTG1, thereby releasing the inhibitory effect of LbTTG1 on salt-gland development. In this manner, LbUBC positively regulates salt-gland development, achieving a dynamic balance in the regulation of salt-gland development and salt tolerance in L. bicolor. This study reveals a synergistic regulatory mechanism involving multiple genes, offering new insights for comprehensively dissecting the molecular regulatory network of salt-gland development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Plant Stress Biology and Genetic Improvement, College of Life Sciences, Shandong Normal University, Ji'nan, 250014, China.
- State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin, 300350, China.
- Shandong Provincial Key Laboratory of Plant Stress Biology and Genetic Improvement, College of Life Sciences, Shandong Normal University, Ji'nan, 250014, China. yuanfang@sdnu.edu.cn.
- National Center of Technology Innovation for Comprehensive Utilization of Saline-Alkali Land, Dongying, Shandong, China. yuanfang@sdnu.edu.cn.
Förderung
- Shandong Province Excellent Youth Science Fund
- National Natural Science Research Foundation of China
Zitieren
APA
Fu, S., Tan, Y., Ma, J., Wang, B., & Yuan, F. (2026). Transcription factor LbUBC positively regulates salt gland development and salt tolerance by directly binding to the LbTTG1 promoter and repressing its transcription. Plant Cell Reports. https://doi.org/10.1007/s00299-026-03950-2
Vancouver
Fu S, Tan Y, Ma J, Wang B, Yuan F. Transcription factor LbUBC positively regulates salt gland development and salt tolerance by directly binding to the LbTTG1 promoter and repressing its transcription. Plant Cell Reports. 2026. doi:10.1007/s00299-026-03950-2
BibTeX
@article{Fu2026,
author = {Fu, Shuyue and Tan, Yuqing and Ma, Jianfei and Wang, Baoshan and Yuan, Fang},
title = {Transcription factor LbUBC positively regulates salt gland development and salt tolerance by directly binding to the LbTTG1 promoter and repressing its transcription},
journal = {Plant Cell Reports},
year = {2026},
doi = {10.1007/s00299-026-03950-2}
}
EUVIMED